Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


05.04.2021

1 AJR Am J Roentgenol
1 Am J Surg Pathol
2 Anticancer Res
1 BJU Int
2 Br J Radiol
1 Clin Cancer Res
1 Clin Imaging
1 Eur Radiol
2 Eur Urol
1 Hum Pathol
3 Int J Radiat Oncol Biol Phys
2 J Magn Reson Imaging
1 J Natl Cancer Inst
2 J Nucl Med
3 J Urol
1 Mod Pathol
1 Nat Rev Urol
1 Oncology
1 Prostate
4 Radiol Imaging Cancer
2 Radiology
1 Urol Int


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PARK SY, Shin N
    Reply to "Tumor Topography for Diagnosis of Prostate Cancer".
    AJR Am J Roentgenol. 2021 Mar 31:W1. doi: 10.2214/AJR.21.25476.
    PubMed        


    Am J Surg Pathol

  2. MCDONALD TM, Epstein JI
    Aberrant GATA3 Staining in Prostatic Adenocarcinoma: A Potential Diagnostic Pitfall.
    Am J Surg Pathol. 2021;45:341-346.
    PubMed         Abstract available


    Anticancer Res

  3. WALTERS C, Reed M, Bartholomew S, Bommareddy A, et al
    Autophagy Induction by alpha-Santalol in Human Prostate Cancer Cells.
    Anticancer Res. 2021;41:1197-1202.
    PubMed         Abstract available

  4. CHOI JH, Choi SM, Lee SW, Jeh SU, et al
    Expression Patterns of ERalpha, ERbeta, AR, SIRT1, SIRT2, and SIRT3 in Prostate Cancer Tissue and Normal Prostate Tissue.
    Anticancer Res. 2021;41:1377-1386.
    PubMed         Abstract available


    BJU Int

  5. GNANAPRAGASAM V, Barrett T, Pacey S, Warren A, et al
    Does modern Active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?
    BJU Int. 2021 Mar 27. doi: 10.1111/bju.15409.
    PubMed         Abstract available


    Br J Radiol

  6. BEDFORD JL, Hanson IM
    Optimisation of a composite difference metric for prompt error detection in real-time portal dosimetry of simulated volumetric modulated arc therapy.
    Br J Radiol. 2021;94:20201014.
    PubMed         Abstract available

  7. YANG FJ, Ai SY, Wu R, Lv Y, et al
    Impact of total variation regularized expectation maximization reconstruction on the image quality of (68)Ga-PSMA PET: a phantom and patient study.
    Br J Radiol. 2021;94:20201356.
    PubMed         Abstract available


    Clin Cancer Res

  8. PACHYNSKI RK, Kim E, Miheecheva N, Kotlov N, et al
    Single cell spatial proteomic revelations on the multiparametric MRI heterogeneity of clinically significant prostate cancer.
    Clin Cancer Res. 2021 Mar 26. pii: 1078-0432.CCR-20-4217.
    PubMed         Abstract available


    Clin Imaging

  9. TOSUN M, Uslu H
    Prebiopsy multiparametric MRI and PI-RADS version 2.0 for differentiating histologically benign prostate disease from prostate cancer in biopsies: A retrospective single-center comparison.
    Clin Imaging. 2021;78:98-103.
    PubMed         Abstract available


    Eur Radiol

  10. LIM CS, Abreu-Gomez J, Flood TA, Carrion I, et al
    Prevalence of prostate cancer in PI-RADS version 2.1 T2-weighted transition zone 'nodule in nodule' and 'homogeneous mildly hypointense area between nodules' criteria: MRI-radical prostatectomy histopathological evaluation.
    Eur Radiol. 2021 Mar 29. pii: 10.1007/s00330-021-07855.
    PubMed         Abstract available


    Eur Urol

  11. KUMARASWAMY A, Welker Leng KR, Westbrook TC, Yates JA, et al
    Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer.
    Eur Urol. 2021 Mar 27. pii: S0302-2838(21)00176.
    PubMed         Abstract available

  12. WILKINSON S, Ye H, Karzai F, Harmon SA, et al
    Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
    Eur Urol. 2021 Mar 27. pii: S0302-2838(21)00207.
    PubMed         Abstract available


    Hum Pathol

  13. WU S, Xie L, Lin SX, Wirth GJ, et al
    Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence.
    Hum Pathol. 2020;104:96-104.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  14. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    PubMed        

  15. ZAORSKY NG
    Prostate and Pelvis on Pause Pending a Pandemic.
    Int J Radiat Oncol Biol Phys. 2020;108:341-342.
    PubMed        

  16. KOONTZ BF
    Through COVID-Colored Glasses: New Perspectives on Same Data.
    Int J Radiat Oncol Biol Phys. 2020;108:338.
    PubMed        


    J Magn Reson Imaging

  17. FENG CH, Conlin CC, Batra K, Rodriguez-Soto AE, et al
    Voxel-level Classification of Prostate Cancer on Magnetic Resonance Imaging: Improving Accuracy Using Four-Compartment Restriction Spectrum Imaging.
    J Magn Reson Imaging. 2021 Mar 31. doi: 10.1002/jmri.27623.
    PubMed         Abstract available

  18. RONG R, Hu L
    Editorial for "Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer".
    J Magn Reson Imaging. 2021 Mar 28. doi: 10.1002/jmri.27622.
    PubMed        


    J Natl Cancer Inst

  19. PLYM A, Penney KL, Kalia S, Kraft P, et al
    Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
    J Natl Cancer Inst. 2021 Apr 1. pii: 6207974. doi: 10.1093.
    PubMed         Abstract available


    J Nucl Med

  20. BAKKER IL, Froberg AC, Busstra MB, Verzijlbergen JF, et al
    GRPr antagonist (68)Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients.
    J Nucl Med. 2021 Mar 31. pii: jnumed.120.258814. doi: 10.2967/jnumed.120.258814.
    PubMed         Abstract available

  21. TRAGARDH E, Simoulis A, Bjartell A, Jogi J, et al
    Tumor detection of (18)F-PSMA-1007 in the prostate gland in patients with prostate cancer using prostatectomy specimens as reference method.
    J Nucl Med. 2021 Mar 31. pii: jnumed.121.261993. doi: 10.2967/jnumed.121.261993.
    PubMed         Abstract available


    J Urol

  22. GONG Y, Fan L, Fei X, Zhu Y, et al
    Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally-Metastatic Prostate Cancer.
    J Urol. 2021 Mar 29:101097JU0000000000001731. doi: 10.1097/JU.0000000000001731.
    PubMed         Abstract available

  23. TANEJA SS
    Urological Oncology: Prostate Cancer.
    J Urol. 2021 Apr 1:101097JU0000000000001746. doi: 10.1097/JU.0000000000001746.
    PubMed        

  24. EASTHAM JA, Heller G, Hillman DW, Hahn OM, et al
    Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance).
    J Urol. 2021 Mar 29:101097JU0000000000001716. doi: 10.1097/JU.0000000000001716.
    PubMed         Abstract available


    Mod Pathol

  25. PERINCHERI S, Levi AW, Celli R, Gershkovich P, et al
    An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.
    Mod Pathol. 2021 Mar 29. pii: 10.1038/s41379-021-00794.
    PubMed         Abstract available


    Nat Rev Urol

  26. CALLEJA E, Rimington P
    The past, present and future: bespoke surgery for older patients with prostate cancer.
    Nat Rev Urol. 2021 Mar 29. pii: 10.1038/s41585-021-00458.
    PubMed        


    Oncology

  27. ACHARD V, Panje CM, Engeler D, Zilli T, et al
    Localized and Locally Advanced Prostate Cancer: Treatment Options.
    Oncology. 2021 Mar 30:1-9. doi: 10.1159/000513258.
    PubMed         Abstract available


    Prostate

  28. LEDET EM, Burgess EF, Sokolova AO, Jaeger EB, et al
    Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
    Prostate. 2021 Apr 1. doi: 10.1002/pros.24123.
    PubMed         Abstract available


    Radiol Imaging Cancer

  29. GOSEIN MA, Narinesingh D, Motilal S, Ramkissoon AP, et al
    Biparametric MRI prior to Radical Radiation Therapy for Prostate Cancer in a Caribbean Population: Implications for Risk Group Stratification and Treatment.
    Radiol Imaging Cancer. 2020;2:e200007.
    PubMed         Abstract available

  30. IBARRA-ROVIRA JJ, Kundra V
    Biopsy in Prostate Cancer. More Is Better.
    Radiol Imaging Cancer. 2020;2:e204019.
    PubMed        

  31. WALLER J, Flavell R, Heath CL
    High Accuracy of PSMA PET in Initial Staging of High-Risk Prostate Cancer.
    Radiol Imaging Cancer. 2020;2:e204025.
    PubMed        

  32. WEISS CR, Solomon AJ
    Confirmatory MRI-guided Biopsy Following Positive Transrectal US-guided Biopsy Results in Improved Risk Stratification and Treatment Planning for Newly Diagnosed Prostate Cancer.
    Radiol Imaging Cancer. 2020;2:e200130.
    PubMed        


    Radiology

  33. LAWHN-HEATH C, Salavati A, Behr SC, Rowe SP, et al
    Prostate-specific Membrane Antigen PET in Prostate Cancer.
    Radiology. 2021 Mar 30:202771. doi: 10.1148/radiol.2021202771.
    PubMed         Abstract available

  34. JADVAR H
    Competitive Advantage of PSMA Theranostics in Prostate Cancer.
    Radiology. 2021 Mar 30:210348. doi: 10.1148/radiol.2021210348.
    PubMed        


    Urol Int

  35. ZHANG Q, Huang J, Xie C, Wu T, et al
    Adjuvant Chemotherapy in High-Risk Prostate Cancer Patients after Primary Local Therapy: Recurrence, Metastasis, and Survival - A Meta-Analysis.
    Urol Int. 2021 Mar 30:1-8. doi: 10.1159/000513941.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: